FDA inspection
Daiichi Sankyo Co., Ltd.: FDA inspection ending Jan 18, 2019
FDA inspection 1080814 · No Action Indicated (NAI) · Iwaki
Key facts
| Inspection ID | 1080814 |
|---|---|
| Firm | Daiichi Sankyo Co., Ltd. |
| FEI number | 3002808054 |
| Address | 389-4, Izumimachi Shimokawa Aza Otsurugi, Izumimachishimogawa |
| City | Iwaki |
| Country | Japan |
| Fiscal year | 2019 |
| Inspection end date | Jan 18, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data